# Drug Order for Rapid Sequence Intubation

> **NCT03420950** · NA · COMPLETED · sponsor: **Hennepin Healthcare Research Institute** · enrollment: 335 (actual)

## Conditions studied

- Acute Respiratory Failure

## Interventions

- **OTHER:** Rapid sequence intubation: sedative first
- **OTHER:** Rapid sequence intubation: paralytic first

## Key facts

- **NCT ID:** NCT03420950
- **Lead sponsor:** Hennepin Healthcare Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-05
- **Primary completion:** 2021-09-29
- **Final completion:** 2021-09-29
- **Target enrollment:** 335 (ACTUAL)
- **Last updated:** 2022-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03420950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03420950, "Drug Order for Rapid Sequence Intubation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03420950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*